Skip to Content

LCE 150 (Stalevo 150 37.5 mg / 200 mg / 150 mg)

Generic Name: carbidopa/entacapone/levodopa

Pill with imprint LCE 150 is Brown, Elliptical / Oval and has been identified as Stalevo 150 37.5 mg / 200 mg / 150 mg. It is supplied by Novartis Pharmaceuticals.

Stalevo 150 is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Stalevo 150 37.5 mg / 200 mg / 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LCE 150

Stalevo 150

Generic Name
carbidopa/entacapone/levodopa
Imprint
LCE 150
Strength
37.5 mg / 200 mg / 150 mg
Color
Brown
Size
15.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Pharmaceuticals
Inactive Ingredients
corn starch, croscarmellose sodium, glycerin, magnesium stearate, mannitol, polysorbate 80, sucrose, ferric oxide red, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00078-0409 Novartis Pharmaceuticals Corporation
00781-5654 Sandoz Inc.

Get help with Imprint Code FAQs.

Related Images for "LCE 150"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.